Walleye Capital’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.6M Sell
104,700
-77,200
-42% -$8.91M 0.05% 322
2025
Q4
$19.1M Sell
181,900
-88,800
-33% -$8.34M 0.06% 312
2025
Q3
$22.7M Sell
270,700
-65,100
-19% -$5.36M 0.09% 217
2025
Q2
$26.6M Buy
335,800
+179,400
+115% +$14.3M 0.1% 152
2025
Q1
$14M Sell
156,400
-103,500
-40% -$9.66M 0.06% 303
2024
Q4
$25.9M Sell
259,900
-93,000
-26% -$9.59M 0.06% 248
2024
Q3
$40.1M Sell
352,900
-75,800
-18% -$9.01M 0.08% 153
2024
Q2
$53.1M Sell
428,700
-130,100
-23% -$16.8M 0.09% 124
2024
Q1
$73.7M Buy
558,800
+125,600
+29% +$15.5M 0.13% 86
2023
Q4
$47.2M Buy
433,200
+284,100
+191% +$29.5M 0.1% 115
2023
Q3
$15.3M Sell
149,100
-58,600
-28% -$6.32M 0.04% 364
2023
Q2
$24M Buy
207,700
+65,700
+46% +$7.46M 0.09% 123
2023
Q1
$15.1M Buy
142,000
+86,100
+154% +$9.3M 0.23% 76
2022
Q4
$6.2M Sell
55,900
-27,500
-33% -$2.81M 0.11% 222
2022
Q3
$7.18M Buy
+83,400
New +$7.45M 0.14% 161
2020
Q1
Sell
-14,672
Closed -$1.27M 1397
2019
Q4
$1.27M Sell
14,672
-117,062
-89% -$9.61M 0.08% 332
2019
Q3
$10.6M Buy
131,734
+67,701
+106% +$5.43M 0.63% 12
2019
Q2
$5.12M Buy
64,033
+23,999
+60% +$1.84M 0.56% 9
2019
Q1
$3.18M Buy
+40,034
New +$2.99M 0.52% 3
2018
Q3
$482K Buy
+7,126
New +$454K 0.22% 134

Other funds holding MRK

Walleye Capital's MRK Position: Q1 2026 in Review

Walleye Capital increased its Merck (MRK) stake by 92% in Q1 2026, buying an estimated $9.69M and bringing the position to 174,672 shares worth $21M. The position accounts for 0.09% of the portfolio, ranked #180.

Walleye Capital first reported a position in MRK in Q2 2020 and has held it in 16 quarters since. The position peaked at $41.2M in Q3 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Walleye Capital held 174,672 shares of Merck worth $21M as of Q1 2026.
  • Walleye Capital bought 83,898 Merck shares in Q1 2026, an estimated $9.69M.
  • Merck made up 0.09% of Walleye Capital's portfolio in Q1 2026, its #180 holding.
  • Walleye Capital first reported a position in Merck in Q2 2020 and has held it in 16 quarters since.
  • Walleye Capital's Merck position peaked at $41.2M in Q3 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.